CancerOption.com Announces the Prestigious Invitation to The 2nd Annual International Conference on Advanced Medicine in Immune Disorders and Cancer.SCOTTSDALE, Ariz.--(BUSINESS WIRE)--June 4, 1999-- -CancerOption President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Arnold Takemoto to Lecture on Adjunctive Immunological Support in the Treatment of Advanced Cancers CancerOption.com, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:CAOP) announced today that President and CEO, Arnold Takemoto has been invited to lecture at The 2nd Annual International Conference on Advanced Medicine in Immune Disorders and Cancer. The conference will be held June 25-27, 1999 in Bad Aibling Bad Aibling is a city and former district seat in Bavaria (Germany) on the river Mangfall, located some 35 miles southeast of Munich at . It is a health resort (mud bath). In the town live approximately 18,002 inhabitants. , Germany and is considered one of the top medical conferences in the world for treatment of advanced cancers. Mr. Takemoto is a chief consultant to physicians and cancer clinics worldwide and teaches doctors new advances in complementary approaches to advanced cancers. Mr. Takemoto also leads workshops at many international conferences as a keynote speaker or guest lecturer. In April 1999, Mr. Takemoto conducted his workshop at the exclusive, invitation only physicians conference, Total Immunity For the Next Millennium in Houston, Texas “Houston” redirects here. For other uses, see Houston (disambiguation). Houston (pronounced /'hjuːstən/) is the largest city in the state of Texas and the . Roger Wist, Vice President of Sales and Marketing comments, "This invitation is an honor for Mr. Takemoto and CancerOption.com and allows the Company international exposure for our cancer protocols and introductory web portal at www.canceroption.com." Mr. Wist further states, "The World Wide Web is increasingly becoming the choice resource for doctors and consumers seeking health and medical related products and content. Companies such as Healtheon WebMD (Nasdaq:HLTH HLTH Health HLTH WebMD Corporation (stock abbreviation, AMEX) ) and Med E America (Nasdaq:MEDE Mede n. A member of an Iranian people, closely related to the Persians, inhabiting ancient Media. [Ultimately from Greek M ) are offering these services. Furthermore, software giant Microsoft (Nasdaq:MSFT MSFT Microsoft (stock symbol) MSFT Movimento Sociale Fiamma Tricolore (Italy) MSFT Multi-Stage Fitness Test MSFT Master of Science in Family Therapy MSFT Macalester Students for Fair Trade ), realizing the growth potential of healthcare and the Internet, is committing capital to this sector." The Company's mission is to provide a format that educates the general public and physicians on the wide variety of methods to enhance the immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. . In addition to traditional medicine, CancerOption.com will provide insight into complementary therapies and offer nutritional supplements Nutritional Supplements Definition Nutritional supplements include vitamins, minerals, herbs, meal supplements, sports nutrition products, natural food supplements, and other related products used to boost the nutritional content of the diet. that support the immune system. The Company understands that it is difficult to make educated decisions, especially when one is dealing with the emotional issue of a life threatening disorder. CancerOption.com will present a clear and concise informational stream of content to help educate in all of the various aspects of cancer and immunological disorders. For more information, please visit our web site at www.canceroption.com. Disclaimer: This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements, which are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks defined in this document and in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion